Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...

If you have attention deficit hyperactivity disorder (ADHD), you may have had a hard time getting your medications refilled because of drug shortages that date back to 2022—which are still ongoing, ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. (Bloomberg) — Shortages of ADHD medications that started ...

“I’ve got X amount of (chemicals) to make Adderall with and lo and behold, by October I’m nearly out because more people are using the drugs than we anticipated,” Burke explained. Another complicating ...

Parsippany-based Watson Pharmaceuticals Inc. last week launched its authorized generic version of Concerta, Johnson & Johnson’s blockbuster attention deficit hyperactive disorder treatment. The launch ...

Angela Myers is a freelance writer covering mental health, wellness and nutrition. She’s also conducted award-winning research on how to better communicate about sexual violence prevention and mental ...

Earlier this year, Clara Pitts got the news she was hoping for: She had been accepted to her dream school, Brigham Young University.It was a feat made all the more joyful for Clara and her family ...

Earlier this year, Clara Pitts got the news she was hoping for: She had been accepted to her dream school, Brigham Young University. It was a feat made all the more joyful for Clara and her family ...

Becca Stanek is an experienced writer and editor who is passionate about exploring the ways we can feel better mentally and physically to get the most out of our lives. She has worked for publications ...

An internal US Food and Drug Administration (FDA) re-examination of previously submitted data has raised concerns that two generic medications used to treat attention ...